Skip to main content
. 2019 Feb 18;33(4):259–266. doi: 10.1038/s41371-019-0176-0

Table 1.

Baseline characteristics by systolic BPV group

Characteristics Low-BPV (n = 171) High-BPV (n = 172) p-Value
Clinical characteristic Male, n (%) 136 (80) 134 (78) 0.714
Age (year-old) 58 ± 13 59 ± 12 0.731
Old age (> 65 years) 51 (30%) 57 (33%) 0.510
BMI (kg/m2) 24 ± 5 25 ± 5 0.783
Medical history Hypertension, n (%) 53 (31) 78 (45) 0.006
Diabetes mellitus, n (%) 34 (20) 41 (24) 0.377
Dyslipidemia, n (%) 12 (7) 11 (6) 0.818
Previous CVA, n (%) 3 (2) 5 (3) 0.481
Familial history, n (%) 6 (3.5) 12 (7.0) 0.150
Smoking, n (%) 114 (66.7) 117 (68) 0.790
Medication ACEi, n (%) 100 (59) 116 (67) 0.086
ARB, n (%) 52 (30) 54 (31) 0.844
Beta blocker, n (%) 114 (67) 99 (58) 0.083
CCB, n (%) 32 (19) 46 (27) 0.076
Statin, n (%) 90 (53) 94 (55) 0.709
Infarction related lesion LAD, n (%) 100 (59) 89 (52) 0.211
LCX, n (%) 15 (9) 18 (11) 0.596
RCA, n (%) 56 (33) 65 (38) 0.33
Number of stenotic coronary vessels 1 Vessel disease, n (%) 77 (45) 72 (42) 0.555
2 Vessel disease, n (%) 51 (30) 60 (35) 0.318
3 Vessel disease, n (%) 43 (25) 40 (23) 0.684
Type of deployed stent Bare metal stent, n (%) 103 (60) 108 (63) 0.566
Drug-eluting stent, n (%) 73 (43) 72 (42) 0.808
Echocardiographic findings LVEDD (mm) 50 ± 9 50 ± 8 0.882
LVESD (mm) 33 ± 8 34 ± 2 0.602
LVEF (%) 53.4 ± 11.8 51.7 ± 11.9 0.167
WMSI 1.39 ± 0.24 1.56 ± 0.37 0.581
Significant MR (≥ Grade 3), n (%) 6 (4) 4 (2) 0.516

BPV blood pressure variability, BMI body mass index, CVA cerebrovascular accident, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, LVEDD left ventricular end diastolic diameter, LVESD left ventricular end systolic diameter, LVEF left ventricular ejection fraction, WMSI wall motion score index, MR mitral regurgitation